Literature DB >> 20573574

Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults.

Ming Fan1, Bing Liu, Yuan Zhou, Xiantong Zhen, Cunlu Xu, Tianzi Jiang.   

Abstract

Previous studies have consistently suggested that the varepsilon4 allele of apolipoprotein E (APOE) gene is a major risk factor for Alzheimer's disease (AD). However, whether the varepsilon2 allele, a possible protective factor for AD, will express its protective effect in terms of cortical thickness in healthy elderly carriers is unclear. The goal of this study is to clarify the effects of APOE genotypes on cortical thickness in nondemented elderly subjects. We used 164 healthy, cognitively normal, elderly subjects, who were grouped into varepsilon2 carriers, varepsilon3 homozygotes, and varepsilon4 carriers respectively. The APOE varepsilon2 carriers had a significant thicker (corrected p<0.05) cortical thickness in the superior temporal cortex compared with the varepsilon3 homozygotes. In addition to this area, the APOE varepsilon2 carriers had a significantly thicker region in the dorsolateral prefrontal cortex (corrected p<0.05) than did the varepsilon4 carriers. These findings suggest that the different alleles of the APOE gene have distinct neuroanatomic effects in elderly healthy subjects and may play specific roles in the development of AD. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573574      PMCID: PMC2954463          DOI: 10.1016/j.neulet.2010.05.092

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

1.  A three-dimensional statistical analysis for CBF activation studies in human brain.

Authors:  K J Worsley; A C Evans; S Marrett; P Neelin
Journal:  J Cereb Blood Flow Metab       Date:  1992-11       Impact factor: 6.200

Review 2.  Tau proteins and neurofibrillary degeneration.

Authors:  M Goedert; M G Spillantini; R A Crowther
Journal:  Brain Pathol       Date:  1991-07       Impact factor: 6.508

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  The apolipoprotein E epsilon 2 allele and decline in episodic memory.

Authors:  R S Wilson; J L Bienias; E Berry-Kravis; D A Evans; D A Bennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

5.  Modeling the relation between neurofibrillary tangles and intellectual status.

Authors:  C Duyckaerts; M Bennecib; Y Grignon; T Uchihara; Y He; F Piette; J J Hauw
Journal:  Neurobiol Aging       Date:  1997 May-Jun       Impact factor: 4.673

Review 6.  Effect of Alzheimer's disease on communication function.

Authors:  E M Frank
Journal:  J S C Med Assoc       Date:  1994-09

7.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Authors:  P Tiraboschi; L A Hansen; E Masliah; M Alford; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

9.  In vitro MR microscopy of the hippocampus in Alzheimer's disease.

Authors:  C T Huesgen; P C Burger; B J Crain; G A Johnson
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  20 in total

Review 1.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  Cortical thickness is linked to executive functioning in adulthood and aging.

Authors:  Agnieszka Z Burzynska; Irene E Nagel; Claudia Preuschhof; Sebastian Gluth; Lars Bäckman; Shu-Chen Li; Ulman Lindenberger; Hauke R Heekeren
Journal:  Hum Brain Mapp       Date:  2011-07-07       Impact factor: 5.038

3.  Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Authors:  Michel J Grothe; Sylvia Villeneuve; Martin Dyrba; David Bartrés-Faz; Miranka Wirth
Journal:  Neurology       Date:  2017-01-06       Impact factor: 9.910

Review 4.  Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Authors:  Marine Fouquet; Florent L Besson; Julie Gonneaud; Renaud La Joie; Gaël Chételat
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

5.  Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk.

Authors:  Fabian Corlier; George Hafzalla; Joshua Faskowitz; Lewis H Kuller; James T Becker; Oscar L Lopez; Paul M Thompson; Meredith N Braskie
Journal:  Neuroimage       Date:  2018-01-28       Impact factor: 6.556

Review 6.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

7.  Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.

Authors:  Shruti Mishra; Tyler M Blazey; David M Holtzman; Carlos Cruchaga; Yi Su; John C Morris; Tammie L S Benzinger; Brian A Gordon
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

Review 8.  Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.

Authors:  Andrew J Saykin; Li Shen; Xiaohui Yao; Sungeun Kim; Kwangsik Nho; Shannon L Risacher; Vijay K Ramanan; Tatiana M Foroud; Kelley M Faber; Nadeem Sarwar; Leanne M Munsie; Xiaolan Hu; Holly D Soares; Steven G Potkin; Paul M Thompson; John S K Kauwe; Rima Kaddurah-Daouk; Robert C Green; Arthur W Toga; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

Review 9.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566

Review 10.  Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.

Authors:  Li Shen; Paul M Thompson; Steven G Potkin; Lars Bertram; Lindsay A Farrer; Tatiana M Foroud; Robert C Green; Xiaolan Hu; Matthew J Huentelman; Sungeun Kim; John S K Kauwe; Qingqin Li; Enchi Liu; Fabio Macciardi; Jason H Moore; Leanne Munsie; Kwangsik Nho; Vijay K Ramanan; Shannon L Risacher; David J Stone; Shanker Swaminathan; Arthur W Toga; Michael W Weiner; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.